Alberto Bossi

Alberto Bossi

Institut Gustave Roussy - - / France
Others
AD Scientific Index ID: 4475361
Gustave Roussy Institute
person_outline Alberto Bossi's MOST POPULAR ARTICLES
1-) Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a …ED Kwon, CG Drake, HI Scher, K Fizazi, A Bossi, AJM Van den Eertwegh, ...The lancet oncology 15 (7), 700-712, 201413392014
2-) Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label …K Fizazi, S Foulon, J Carles, G Roubaud, R McDermott, A Fléchon, ...The Lancet 399 (10336), 1695-1707, 2022
3-) Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...European urology 73 (2), 178-211, 2018
4-) Oral relugolix for androgen-deprivation therapy in advanced prostate cancerND Shore, F Saad, MS Cookson, DJ George, DR Saltzstein, R Tutrone, ...New England Journal of Medicine 382 (23), 2187-2196, 20204092020
5-) Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ...European urology 77 (4), 508-547, 2020